
Chris Danes, Scientific Director, US Medical Affairs for Lung Cancer, Takeda Oncology
Advertisement
Articles by Chris Danes, Scientific Director, US Medical Affairs for Lung Cancer, Takeda Oncology

Advertisement
Latest Updated Articles
Bringing Precision Medicine to Community Oncology is Going to Require Bigger ThinkingPublished: May 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5
